...of the expansion, and Altrazeal AG could not be reached (see BioCentury, Sept. 23, 2013). Melmed Holdings AG...

...nanoparticle aggregate technology in the U.S. for wound management, and Altrazeal markets it in Austria. Melmed Holdings AG...

...company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management (see BioCentury, Jan. 23). Melmed Holdings AG...

...company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management (see BioCentury, Jan. 23). Melmed Holdings AG...

...company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management. Details were not disclosed. Melmed Holdings AG...

...April 2012. Terms were not disclosed (see BioCentury, Oct. 24). Uluru Inc. (NYSE-A:ULU), Addison, Texas Melmed Holdings AG...

...Melmed plans to launch the product in Germany next quarter. Uluru Inc. (NYSE-A:ULU), Addison, Texas Melmed Holdings AG...